ARTELO BIOSCIENCES, INC.
ARTL · Pharmaceutical Preparations
Latest available SEC filing: 10-Q/A ·
Latest disclosures
-
Form 10-Q/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Matsui Connie: Form 4
Insider disclosure · Filed · Report period 17 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001621221 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ARTL on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, 92075
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- REACTIVE MEDICAL INC. (to 17 Apr 2017), KNIGHT KNOX DEVELOPMENT CORP. (to 06 Feb 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields